Andrew Judge

Has grant

Professor

University of Florida

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Andrew Judge is a faculty member at the University of Florida, United States. His research primarily focuses on cancer cachexia, with recent publications exploring the mechanisms behind muscle wasting in pancreatic cancer and the role of specific transcriptional programs in skeletal muscle. He also investigates interventions to mitigate muscle atrophy and enhance physical performance in aging populations and disease models.

Recent Grants

Grant: Close

Development of Novel Therapeutics for Cancer Cachexia

Open Date: 2023-05-15

Close Date: 2024-03-31

Grant: Open

The Complement System and Cancer Cachexia

Open Date: 2022-08-01

Close Date: 2027-07-31

Grant: Close

Understanding and Improving Therapies for the Muscular Dystrophies

Open Date: 2021-08-01

Close Date: 2025-07-31

Grant: Close

Ursolic acid as a countermeasure to cancer cachexia

Open Date: 2021-05-17

Close Date: 2024-04-30

Grant: Close

Team-based Interdisciplinary Cancer Research Training Program

Open Date: 2021-04-01

Close Date: 2026-03-31

Articles (12)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

UNITED STATES

View details

Blake Rasmussen

Professor

University of Texas Health Science Center at San Antonio

UNITED STATES

View details

Matthew Schabath

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES

View details

Michael Deyhle

Assistant Professor

University of New Mexico

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrew Judge

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

Correction: Park et al. Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration. <i>Cancers</i> 2024, <i>16</i>, 2364

Complement pathway activation mediates pancreatic cancer–induced muscle wasting and pathological remodeling

Identification of a senescence-associated transcriptional program in skeletal muscle of cachectic pancreatic-tumor-bearing mice

Role of myofiber-specific FoxP1 in pancreatic cancer-induced muscle wasting

Ursolic Acid Induces Beneficial Changes in Skeletal Muscle mRNA Expression and Increases Exercise Participation and Performance in Dogs with Age-Related Muscle Atrophy.

Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration

Blocking muscle wasting via deletion of the muscle-specific E3 ligase MuRF1 impedes pancreatic tumor growth

The transcription regulator ATF4 is a mediator of skeletal muscle aging.

Depleting Ly6G Positive Myeloid Cells Reduces Pancreatic Cancer-Induced Skeletal Muscle Atrophy

Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery

FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness

Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle

Collaborators (9)

Tina Mason

Sarah Judge

Scott Ebert

Daniel Delitto

Christopher Adams

Daria Neyroud

Blake Rasmussen

Matthew Schabath

Michael Deyhle

Make your next move.